已收盤 05-08 16:00:00 美东时间
-0.470
-0.77%
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
Fortive (FTV) increased its share buyback program, with up to 20M shares now available for repurchase, including shares that were available prior to such increase. These shares available for repurchas...
05-04 19:10
The shares available for repurchase under the General Share Repurchase Program are in addition to approximately $66.7 million available under the $550 million special purpose share repurchase program previously adopted
05-04 18:33
In a report released today, Julian Mitchell from Barclays maintained a Hold rat...
05-04 16:57
今日重点评级关注:Benchmark:维持史密斯微软件"买入"评级,目标价从2美元升至2.5美元;Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元
05-04 16:04
RBC Capital analyst Deane Dray maintains Fortive (NYSE:FTV) with a Sector Perform and raises the price target from $59 to $63.
05-02 00:48
U.S. RESEARCH ROUNDUP- Caterpillar, Textron, Wesco International May 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Caterpillar, Textron and Wesco International, on Friday. HIGHLIGHTS * Arrowhead Pharmaceuticals ARWR.
05-01 15:29
Fortive (NYSE:FTV) held its first-quarter earnings conference call on Thursday....
05-01 01:17
Fortive shares are trading lower. The company reported Q1 financial results.
05-01 00:43
华盛资讯4月30日讯,Fortive Corp.公布2026财年Q2业绩,公司Q2营收10.69亿美元,同比增长7.7%,归母净利润1.36亿美元,同比增长21.1%。
04-30 19:47